Gas Chromatography in Diagnostic Biochemistry of Abnormal Valine Metabolism Hugh N. Tucker and Samuel V. Molinary
Amino acids in biological fluids can be rapidly and accurately quantitated by gas chromatography.
Modification of existing gas-chromatographic techniques allow as little as 25 tl of biological fluids to be analyzed, compatible with sample sizes easily obtained in pediatric studies. Simplified diagnostic biochemical evaluation of a suspected aminoaciduria can be begun at birth, or shortly after. Normal amino acid patterns are compared with those found in a patient with abnormal amino acid concentrations. Gas chromatographic evidence is presented as a diagnostic aid in the evaluation of a patient with abnormal valine metabolism. Gehrke et al. (6, 7) proposed GC of the N-trifluoroacetyl n-butyl esters of amino acids as the method of choice. Darbre and Islam (8) reported removal of excess TFAA by evaporation of the cold sample under reduced pressure without loss of the compounds of interest. Small quantities of the more volatile amino acids are not then masked by the tailing TFAA peak. Lachovitzki and Bjorklund (9) confirmed a combination of these methods.
The current study presents the gas-chromatographic evaluation of the plasma, urine, and cerebrospinal fluid of a developmentally delayed 15-monthold child with abnormally high plasma valine concentrations.
The initial data suggested a rare inborn error of metabolism (10) (11) (12) .
Complete evaluation of the patient required methods of quantitating plasma amino acids in small samples that could easily be obtained from a pediatric patient. We accomplished this by modifying the derivatization methods of Gehrke #{232}t al. (6).
Materials and Methods

Sample Preparation
Centrifuge 1 ml of heparinized whole blood, urine, or cerebrospinal fluid at 3000 rpm for 10 mm at 4 #{176}C. Deproteinize exactly 500 jl of the supernatant fluid with 4.5 ml of TCA (6 mol/liter) and mix vigorously with the aid of a vortex-type mixer. Let stand at room temperature for 10 mm, then recentrifuge. Remove the supernatant fraction quantitatively and resuspend the remaining pellet with 4-5 ml of (6 mol/ liter) TCA and treat as before. 
). the patient to normal values by marks at appropriate levels for each amino acid. Figure 2A is a strip-chart recording of a standard run of known amino acids of equimolar concentrations (2.5 zmol/ml).
Calculations are done according to Gehrke et al. (6) . Molar response factors are calculated for each amino acid. The area under the peak is proportional to the concentration of the amino acid relative to its molar response factor and to the concentration of the internal standard. The internal standard, n-butyl stearate, is chosen in preference to ornithine, which is present in biological samples. Glutamine and asparagine are converted to their respective acid forms during derivatization. The peak separated during GC analysis represent the total of both forms of these compounds.
All derivatives are stable for at least two weeks, except for methionine, which begins to decompose 2-3 h after acylation, as also reported by Gehrke et al. (6) . Figure 2B is the strip-chart recording of the amino acid profile of a clinically normal patient. The profile is dominated by the glutamine-glutamic acid peak ( Figure 2B, 2) appearing before the internal standard. Figure 2C is the plasma profile of the patient (AMH), showing a marked elevation of the valine peak ( Figure 2C, 1) . Leucine and proline also appear to be slightly elevated, but are within normal limits (see Table 2 ). The urinary profile ( Figure 2D ) of a casual specimen, collected at the time of the first examination, shows a marked increase in valine (Figure 2D, 1) concentration.
The identity of the various peaks in both the patient and standard was confirmed by mass-spectral analysis by Finnigan Laboratories, Sunnyvale, Calif. 94086. Table 3 compares normal urinary amino acid concentration and those of the patient.
The profile for cerebrospinal fluid ( Figure 2E ) from the same patient was not remarkable, only glutamine-glutamic acid being found in measurable amounts ( Figure 2E, 2) .
Further evidence of an inborn error of metabolism was sought by evaluating the branched-chain amino acid pathways.
Loading tests requiring serial sampling could be easily accomplished with use of 50 jzl for each sample. On consecutive days, we did separate oral loading tests, in which L-isomers of valine, leucine, isoleucine, and a phenylalanine control were used. All plasma amino acid concentrations were unaffected except for the four involved in the study (Figure 3) . Phenylalanine concentrations (for phenylalanine loading only) were measured by modi-
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o Arginine, histidine, and cystine may be quantitated from the same derivative on 1% OV-1 7 by use of the same temperature program.
"Normal ranges calculated from data on 31 clinically normal pediatric patients.
C Patient AMH. U Plus asparagine. e Plus glutamine. (13) . In the fasting patient, phenylalanine concentrations as measured by the spectrofluorometric and GC methods agreed closely (Figure 3 ). The plateau in valine concentration was delayed, occurring at 2 h with a decreased rate of plasma clearance. Close agreement between all amino acid concentrations other than the elevation of the exogenous amino acid provides additional evidence of the GC quantitative method. Valine was unexplainably increased during the isoleucine load. The purity of each of the administered amino acids was checked and no contaminating compounds were found.
Discussion
Existing GC techniques have been modified to advantage in this study. We find the present method to be an improvement over the procedure suggested by Gehrke et al. (6) . Increasing the temperature during derivatization from room temperature for methylation, 100 #{176}C for transesterification and 150 #{176}C for the final acylation, produced several unidentifiable peaks with our small quantity of sample. Maintain--ing a constant derivatization temperature appears to eliminate the occasional unidentifiable peak and the per mole response of the chromatograph appears to be equal, if not greater. Removal of the TFAA before injection has two advantages:
(a) the TFAA peak that could mask alanine and valine in samples of such low concentration is eliminated, and (b) amounts of TFAA used during acylation to prevent complete volatilization of the liquid phase can be increased. Increasing the reaction volume to 1 ml for each step allows all derivatization to be accomplished in 16 x 75 mm Pyrex culture tubes. Commercially available micro-acetylation tubes (Regis Chemical Co.) were tried with no success.
Diminishing the required quantity of the initial specimen is of obvious importance for study of pediatric patients.
For example, loading tests requiring serial sampling could not be performed if 5-ml samples (6) must be used. Current studies demonstrate that as little as 25 ,l of plasma can be treated as described without interfering with the quantitative reliability of the technique, simply by adjusting the amount of internal standard appropriate for the sample size. At present we are routinely using 5O-tl samples, which may be easily obtained from a fingeror heel-stick.
Results indicate that the method is easily adaptable to these small samples. References derivatives may be attributable in part to the substitution of helium for nitrogen as a carrier gas.
Multiple samples (six to nine) may easily be prepared simultaneously in one day followed by instrumental analysis requiring less than 1 h of instrument time per sample. The longer time required for amino acid analysis by ion-exchange equipment necessarily restricts the number of samples that can be run in a day.
Derivatization must be done with care, but we find the method to be reliable and reproducible. Quantitation by GC compares favorably with that by spectrofluorometric or ion-exchange techniques.
